Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 2
2006 1
2007 2
2008 1
2017 1
2018 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular risk and lifetime benefit from preventive treatment in type 2 diabetes: A post hoc analysis of the CAPTURE study.
Østergaard HB, Humphreys V, Hengeveld EM, Honoré JB, Mach F, Visseren FLJ, Westerink J, Yadav G, Mosenzon O; CAPTURE investigators. Østergaard HB, et al. Among authors: humphreys v. Diabetes Obes Metab. 2023 Feb;25(2):435-443. doi: 10.1111/dom.14887. Epub 2022 Oct 24. Diabetes Obes Metab. 2023. PMID: 36199242 Free PMC article.
Pharmacogenetic analyses of 2183 patients with advanced colorectal cancer; potential role for common dihydropyrimidine dehydrogenase variants in toxicity to chemotherapy.
Madi A, Fisher D, Maughan TS, Colley JP, Meade AM, Maynard J, Humphreys V, Wasan H, Adams RA, Idziaszczyk S, Harris R, Kaplan RS, Cheadle JP. Madi A, et al. Among authors: humphreys v. Eur J Cancer. 2018 Oct;102:31-39. doi: 10.1016/j.ejca.2018.07.009. Epub 2018 Aug 13. Eur J Cancer. 2018. PMID: 30114658 Clinical Trial.
Comprehensive pharmacogenetic profiling of the epidermal growth factor receptor pathway for biomarkers of response to, and toxicity from, cetuximab.
Madi A, Fisher D, Maughan TS, Colley JP, Meade AM, Tejpar S, Van den Bosch B, Maynard J, Humphreys V, Wasan H, Adams RA, Idziaszczyk S, Harris R, Kaplan RS, Cheadle JP. Madi A, et al. Among authors: humphreys v. J Med Genet. 2017 Aug;54(8):567-571. doi: 10.1136/jmedgenet-2016-104317. Epub 2017 Mar 10. J Med Genet. 2017. PMID: 28283541
Inherited predisposition to colorectal adenomas caused by multiple rare alleles of MUTYH but not OGG1, NUDT1, NTH1 or NEIL 1, 2 or 3.
Dallosso AR, Dolwani S, Jones N, Jones S, Colley J, Maynard J, Idziaszczyk S, Humphreys V, Arnold J, Donaldson A, Eccles D, Ellis A, Evans DG, Frayling IM, Hes FJ, Houlston RS, Maher ER, Nielsen M, Parry S, Tyler E, Moskvina V, Cheadle JP, Sampson JR. Dallosso AR, et al. Among authors: humphreys v. Gut. 2008 Sep;57(9):1252-5. doi: 10.1136/gut.2007.145748. Epub 2008 May 30. Gut. 2008. PMID: 18515411
Effect of luteinizing hormone (LH), pregnancy specific protein B (PSPB), or arachidonic acid (AA) on ovine endometrium of the estrous cycle or placental secretion of prostaglandins E2 (PGE2) and F2alpha (PGF2alpha) and progesterone in vitro.
Weems YS, Kim L, Humphreys V, Tsuda V, Weems CW. Weems YS, et al. Among authors: humphreys v. Prostaglandins Other Lipid Mediat. 2003 Apr;71(1-2):55-73. doi: 10.1016/s0090-6980(03)00004-2. Prostaglandins Other Lipid Mediat. 2003. PMID: 12749594
Effect of luteinizing hormone (LH), pregnancy-specific protein B (PSPB), or arachidonic acid (AA) on secretion of progesterone and prostaglandins (PG) E (PGE; PGE(1) and PGE(2)) and F(2alpha) (PGF(2alpha)) by ovine corpora lutea of the estrous cycle or pregnancy in vitro.
Weems YS, Kim L, Humphreys V, Tsuda V, Blankfein R, Wong A, Weems CW. Weems YS, et al. Among authors: humphreys v. Prostaglandins Other Lipid Mediat. 2007 Nov;84(3-4):163-73. doi: 10.1016/j.prostaglandins.2007.08.002. Epub 2007 Aug 15. Prostaglandins Other Lipid Mediat. 2007. PMID: 17991618